His primary scientific interests are in Internal medicine, Surgery, Cancer, Prospective cohort study and Risk factor. His work deals with themes such as Gastroenterology, Gynecology and Oncology, which intersect with Internal medicine. His work carried out in the field of Surgery brings together such families of science as Gastrectomy, Clinical trial and Lymphadenectomy.
His Cancer research is mostly focused on the topic Stomach cancer. His study in Prospective cohort study is interdisciplinary in nature, drawing from both Diet Records, Epidemiology, Relative risk, Isoflavones and Cohort. His biological study spans a wide range of topics, including Odds ratio, Intestinal mucosa and Cohort study.
Internal medicine, Surgery, Colorectal cancer, Cancer and Oncology are his primary areas of study. His Internal medicine study frequently draws connections between related disciplines such as Gastroenterology. His research links Colectomy with Surgery.
His studies examine the connections between Colorectal cancer and genetics, as well as such issues in Lymph node, with regards to Dissection and Lymphovascular invasion. His work in Cancer covers topics such as Risk factor which are related to areas like Odds ratio. His research integrates issues of Gastrectomy and Clinical trial in his study of Randomized controlled trial.
His main research concerns Surgery, Colorectal cancer, Internal medicine, Randomized controlled trial and Radiology. The Surgery study combines topics in areas such as Rectal carcinoma and Subgroup analysis. His Colorectal cancer research includes themes of Rectum, Lymph node, Propensity score matching, General surgery and Dissection.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology. His Randomized controlled trial study combines topics in areas such as Physical therapy and Survival analysis. His Cancer study incorporates themes from Clinical research, Quality of life, Gynecology and Intention-to-treat analysis.
The scientist’s investigation covers issues in Surgery, Randomized controlled trial, Laparoscopic surgery, Colorectal cancer and Clinical trial. His Surgery research incorporates themes from Colectomy, Subgroup analysis and Low rectal cancer. His Randomized controlled trial research is multidisciplinary, incorporating elements of Psychological intervention and Survival analysis.
Colorectal cancer is a subfield of Internal medicine that Seiichiro Yamamoto investigates. His work on Internal medicine is being expanded to include thematically relevant topics such as Gynecology. His Clinical endpoint study in the realm of Clinical trial interacts with subjects such as Attendance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer
Kazumasa Noda;Yutaka Nishiwaki;Masaaki Kawahara;Shunichi Negoro.
The New England Journal of Medicine (2002)
D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
Mitsuru Sasako;Takeshi Sano;Seiichiro Yamamoto;Yukinori Kurokawa.
The New England Journal of Medicine (2008)
Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer
Toshimi Takano;Yuichiro Ohe;Hiromi Sakamoto;Koji Tsuta.
Journal of Clinical Oncology (2005)
Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501
Takeshi Sano;Mitsuru Sasako;Seiichiro Yamamoto;Atsushi Nashimoto.
Journal of Clinical Oncology (2004)
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
Narikazu Boku;Seiichiro Yamamoto;Haruhiko Fukuda;Kuniaki Shirao.
Lancet Oncology (2009)
Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)
Atsushi Ohtsu;Yasuhiro Shimada;Kuniaki Shirao;Narikazu Boku.
Journal of Clinical Oncology (2003)
Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.
Hirokazu Okayama;Takashi Kohno;Yuko Ishii;Yoko Shimada.
Cancer Research (2012)
Soy, Isoflavones, and Breast Cancer Risk in Japan
Seiichiro Yamamoto;Tomotaka Sobue;Minatsu Kobayashi;Satoshi Sasaki.
Journal of the National Cancer Institute (2003)
Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial.
Mitsuru Sasako;Takeshi Sano;Seiichiro Yamamoto;Motonori Sairenji.
Lancet Oncology (2006)
Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial
Noriaki Ohuchi;Akihiko Suzuki;Tomotaka Sobue;Masaaki Kawai.
The Lancet (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: